Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF- (Record no. 29698079)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01421 a2200421 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518041004.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201910s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1793-6853 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1142/S0192415X19500484 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hsu, Fei-Ting |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20191017 |
| 245 00 - TITLE STATEMENT | |
| Title | Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF- |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The American journal of Chinese medicine |
| Date of publication, distribution, etc. | 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 913-931 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Phytogenic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biflavonoids |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glioblastoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | MAP Kinase Signaling System |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred BALB C |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | NF-kappa B |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oncogenes |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phytotherapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Cells, Cultured |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chiang, I-Tsang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kuo, Yu-Cheng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hsia, Te-Chun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lin, Chin-Chung |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Yu-Chang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chung, Jing-Gung |
| 773 0# - HOST ITEM ENTRY | |
| Title | The American journal of Chinese medicine |
| Related parts | vol. 47 |
| -- | no. 4 |
| -- | p. 913-931 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1142/S0192415X19500484">https://doi.org/10.1142/S0192415X19500484</a> |
| Public note | Available from publisher's website |
No items available.